We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
Bristol Myers Squibb (BMS) has received the European Commission (EC) approval for Opdivo (nivolumab) plus chemotherapy (fluoropyrimidine- and platinum-based) to treat certain gastrointestinal cancers. The Opdivo combination was
Novartis has agreed with BioNTech to offer its manufacturing capacity and capabilities to support the fill and finish operations of the Pfizer-BioNTech Covid-19 vaccine. Under the terms of
The US Food and Drug Administration (FDA) has authorised booster shots of the Covid-19 vaccines from Moderna and Johnson & Johnson (J&J) for emergency use in the US.
LumiraDx has received India’s Central Drugs Standard Control Organisation (CDSCO) approval for emergency use of its SARS-CoV-2 Antigen test in the country. The SARS-CoV-2 Antigen test is a
Sage Therapeutics and Biogen have unveiled plans to file a New Drug Application (NDA) with the US Food and Drug Administration (FDA) seeking approval of their investigational depression
Dr. Reddy’s Laboratories announced that the US Food and Drug Administration (FDA) has approved its Abbreviated New Drug Application (ANDA) for Lenalidomide Capsules. Lenalidomide is a generic version
Gilead Science has secured the expanded US Food and Drug Administration (FDA) approval for a low-dose formulation of its Biktarvy to treat children with HIV. The US FDA
Pfizer Canada and BioNTech have filed a Supplemental New Drug Submission (sNDS) with Health Canada for use of its Covid-19 vaccine Comirnaty in children aged five to 12
Roche has secured the US Food and Drug Administration (FDA) approval for its Tecentriq (atezolizumab) to treat a type of non-small cell lung cancer (NSCLC). The US regulator
Johnson & Johnson (J&J) announced that the US Food and Drug Administration (FDA)’s advisory committee has recommended granting emergency use authorisation (EUA) for a booster dose of its